UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 166 filers reported holding UNIQURE NV in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $149,000 | +2.8% | 8 | 0.0% | 0.00% | – |
| Q1 2022 | $145,000 | -12.7% | 8 | 0.0% | 0.00% | – |
| Q4 2021 | $166,000 | -99.9% | 8 | -99.8% | 0.00% | -100.0% |
| Q3 2021 | $151,370,000 | +14.2% | 4,729 | -1.0% | 0.04% | +20.0% |
| Q2 2021 | $132,503,000 | -0.4% | 4,775 | +20.9% | 0.03% | -21.1% |
| Q1 2021 | $133,069,000 | +56.3% | 3,950 | +67.6% | 0.04% | +52.0% |
| Q4 2020 | $85,154,000 | +106.0% | 2,357 | +64.3% | 0.02% | +257.1% |
| Q4 2018 | $41,344,000 | – | 1,435 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |